460 related articles for article (PubMed ID: 31077220)
1. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
[TBL] [Abstract][Full Text] [Related]
2. Title: pancreatic-type mixed acinar neuroendocrine carcinoma of the stomach: a case report and review of the literature.
Ooe Y; Watanabe K; Hashimoto I; Takenaka S; Ojima T; Yamamoto S; Fujii H
Diagn Pathol; 2021 Feb; 16(1):11. PubMed ID: 33531019
[TBL] [Abstract][Full Text] [Related]
3. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
[TBL] [Abstract][Full Text] [Related]
4. Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.
Nießen A; Schimmack S; Weber TF; Mayer P; Bergmann F; Hinz U; Büchler MW; Strobel O
Pancreatology; 2021 Jan; 21(1):224-235. PubMed ID: 33309225
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
[TBL] [Abstract][Full Text] [Related]
6. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
[TBL] [Abstract][Full Text] [Related]
7. Gastric Amphicrine Carcinoma Showing Neuroendocrine and Pancreatic Acinar Cell Differentiation. Lesson from a Challenging Case Opening New Perspectives in the Diagnostic Work-Up of Gastric Neuroendocrine Neoplasms.
Sciarra A; Uccella S; Hiroz P; Fournier I; Soubeyran V; Finzi G; La Rosa S
Endocr Pathol; 2023 Sep; 34(3):349-357. PubMed ID: 37249796
[TBL] [Abstract][Full Text] [Related]
8. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562
[TBL] [Abstract][Full Text] [Related]
9. Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy.
Mastrosimini MG; Mafficini A; Tondulli L; Milella M; Piccoli P; Mattiolo P; Fassan M; Hong SM; Scarpa A; Luchini C
Virchows Arch; 2023 Sep; 483(3):415-419. PubMed ID: 37581694
[TBL] [Abstract][Full Text] [Related]
10. Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms of the Pancreas.
Tsvetkova V; Luchini C
Surg Pathol Clin; 2022 Sep; 15(3):555-563. PubMed ID: 36049836
[TBL] [Abstract][Full Text] [Related]
11. Primary Pure Pancreatic -Type Acinar Cell Carcinoma of the Stomach: A Rare Entity with a Difficult Diagnosis and Review of the Literature.
Paseiro-Crespo G; García-Nebreda M; Roldán Cortés D; De la Peña Navarro I; Álvaro Cifuentes E; Marqués Medina E; Abad-Motos A
Int J Surg Pathol; 2022 Aug; 30(5):528-538. PubMed ID: 35068223
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
13. Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens.
Manfrin E; Parisi A; Stefanizzi L; D'Onofrio M; Bernardoni L; Crino SF; Pelosi G; Pancione M; Giordano G; Sina S; Remo A
Pathol Res Pract; 2021 Oct; 226():153593. PubMed ID: 34481211
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of pancreatic acinar differentiation in gastric adenocarcinoma: report of a case and immunohistochemical study of 111 additional cases.
Lee H; Tang LH; Veras EF; Klimstra DS
Am J Surg Pathol; 2012 Mar; 36(3):402-8. PubMed ID: 22082608
[TBL] [Abstract][Full Text] [Related]
15. Gastric carcinoma resembling pancreatic mixed acinar-endocrine carcinoma.
Fukunaga M
Hum Pathol; 2002 May; 33(5):569-73. PubMed ID: 12094386
[TBL] [Abstract][Full Text] [Related]
16. Surgical and molecular pathology of pancreatic neoplasms.
Hackeng WM; Hruban RH; Offerhaus GJ; Brosens LA
Diagn Pathol; 2016 Jun; 11(1):47. PubMed ID: 27267993
[TBL] [Abstract][Full Text] [Related]
17. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in gastric amphicrine carcinomas and comparison with gastric mixed neuroendocrine-non-neuroendocrine neoplasms.
Sun L; Wang C; Zhang J; Shao B; Zhao S; Guo Y; Li X; Sun Y
Mod Pathol; 2022 Jun; 35(6):808-815. PubMed ID: 34839352
[TBL] [Abstract][Full Text] [Related]
19. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
Jiao Y; Yonescu R; Offerhaus GJ; Klimstra DS; Maitra A; Eshleman JR; Herman JG; Poh W; Pelosof L; Wolfgang CL; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N; Wood LD
J Pathol; 2014 Mar; 232(4):428-35. PubMed ID: 24293293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
